Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of €113.18 billion as of April 25, 2025. Its market cap has increased by 43.40% in one year.

Market Cap

113.18B

Enterprise Value

128.22B

Revenue

26.59B

Ranking

n/a

PE Ratio

20.51

Stock Price

€90.40

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 113.18B, an increase of 58,097.31%. That is a compound annual growth rate of 21.08%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	113.18B	1.79%
Dec 31, 2024	111.19B	21.76%
Dec 29, 2023	91.32B	-9.36%
Dec 30, 2022	100.75B	25.80%
Dec 31, 2021	80.09B	34.14%
Dec 31, 2020	59.70B	-18.50%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Merck KGaA	52.43B
Siemens Healthineers AG	50.97B
Fresenius SE & Co. KGaA	22.24B
Bayer Aktiengesellschaft	21.72B
Sartorius Aktiengesellschaft	14.43B
Fresenius Medical Care AG	12.35B
Carl Zeiss Meditec AG	5.15B
Fielmann Group AG	3.71B

Market Cap Rankings